glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Cardiovascular, Kidney, and Safety Outcomes – GLP1 Receptor Agonists vs SGLT2-I

It specifically names patients with prediabetes, early insulin resistance, or a BMI in the 25 to 29 range as candidates who may benefit from structured lifestyle intervention before pharmaceutical escalation

And I think that thats where some of the research is gonna have to go in the future is to find out whats the combination, combinatorial effect of the GLP-1s with a little bit of activity

And using both medications at the same time raises your risk of side effects that both drugs can cause, including diarrhea, nausea, and vomiting

This evolving integration of metabolic and aesthetic therapies reflects the growing importance of the aesthetic courses for doctors at HubMed Ed , which support clinicians in staying at the forefront of peptide-based interventions

Do not give yourself extra medication or double your next dose unless you are told to do so

Chitra Gantra explains that she's in favor of prescribing GLP-1s to adults until they're age 65 (via American Academy of Medical Colleges)